https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50560 Wed 28 Feb 2024 15:26:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39545 Wed 27 Jul 2022 14:26:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45258 Wed 26 Oct 2022 19:26:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47843 Wed 24 May 2023 15:59:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55197 Wed 24 Apr 2024 13:07:49 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55183 Wed 24 Apr 2024 09:48:10 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37623 Wed 23 Feb 2022 16:07:02 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53359 Wed 22 Nov 2023 12:31:43 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37439 Wed 22 Mar 2023 10:17:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48553 Wed 22 Mar 2023 09:14:56 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48550 Wed 22 Mar 2023 08:59:17 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48549 Wed 22 Mar 2023 08:55:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40930 Wed 20 Jul 2022 11:38:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38502 71BM ternary blend show efficiencies up to 10.2% (device active area 0.88 cm²), which is the highest value reported to date (for in-air slot-die-coated devices). This is achieved through ink modifications and optimizations as well as electrode and active layer compositional optimizations, leading to an impressive efficiency retention of 0.86 compared to the in-literature optimized small-scale devices.]]> Wed 19 Apr 2023 11:52:55 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38143 Wed 15 Feb 2023 11:16:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50554 Wed 13 Mar 2024 19:04:39 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52814 Wed 13 Mar 2024 19:03:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50353 Wed 07 Feb 2024 15:00:57 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46017 Wed 07 Feb 2024 14:59:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39876 Wed 06 Jul 2022 08:57:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52199 Wed 04 Oct 2023 15:49:57 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51107 20% in TC and TCH in routine clinical practice should guide primary GCSF use in accordance with international guidelines.]]> Wed 04 Oct 2023 11:54:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38917 2O₂ due to the isolation of the Au nanoparticles (AuNPs) from the PtNPs layer. Then the weak acidity of H₂O₂ can trigger the disassembly and reassembly of the AuNPs, resulting in the Janus distribution of large AuNPs aggregates. Such reconstruction of JMPA leads to the contact between PtNPs and AuNPs aggregates, thus changing the propulsion mechanism to self-electrophoresis. The asymmetric and aggregated AuNPs also enable the generation of a thermal gradient under laser irradiation, which propels the JMPA nanomotors by self-thermophoresis. Such multi-phoretic propulsion offers considerable promise for developing advanced nanomachines with a stimuli-responsive switch of propulsion modes in biomedical applications.]]> Wed 02 Mar 2022 15:43:14 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52888 Tue 31 Oct 2023 11:19:22 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48666 85% of eligible participants. The only significant difference between mean baseline and 12-mo performance was an improvement in 6MWT in children 3-6 y old (P = .008). This age group also had the largest mean % improvement in performance in all other timed functional testing. In children >7 y, the slope of change on timed functional tests decreased or plateaued, with further reductions in performance in children ≥10 y. Participants with CTG repeat lengths <500 did not perform differently than those with repeat lengths >1000. Conclusions The 6MWT, 10 Meter Run, and 4 Stair Climb were the most feasible measures. Our findings are consistent with the clinical profile and prior cross-sectional data, helping to establish reasonable expectations of functional trajectories in this population as well as identifying points in which therapeutic interventions may be best studied. Further study of outcomes in children >10 y old and <3 y is warranted, but this new information will assist planning of clinical trials in the CDM population.]]> Tue 28 Mar 2023 10:11:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51996 Tue 26 Sep 2023 11:08:17 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51997 Tue 26 Sep 2023 11:07:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39564 Tue 26 Jul 2022 15:25:02 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52728 Tue 24 Oct 2023 08:38:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52722 Tue 24 Oct 2023 08:32:07 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46418 Tue 22 Nov 2022 13:53:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48557 Tue 21 Mar 2023 15:38:12 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48559 Tue 21 Mar 2023 15:37:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50313 60 minutes after waking), and were categorised as low smoking dependency compared with those aged 35 years and over. One-third of women (153 [35.7%]) had ever used NRT and/or SSM. A greater proportion of older women (35–49-year-olds) had sustained a quit attempt for years (62/149 [45.6%]) and reported trying NRT and/or SSM (78/149 [52.4%]) than women in younger age groups. Quitting suddenly rather than gradually was significantly associated with sustained abstinence (prevalence ratio, 1.27 [95% CI, 1.10–1.48]). Among women who had never used NRT or SSM, most (219/275 [79.6%]) reported reasons for this in the category of attitudes and beliefs. NRT and SSM use was also more likely among women who were confident talking to their doctor about quitting (odds ratio, 2.50 [95% CI, 1.23–5.10]) and those who received most of their information from a health professional (odds ratio, 1.71 [95% CI, 1.11–2.63]). Conclusion: Aboriginal and Torres Strait Islander women want to quit smoking and are making attempts to quit. Quitting suddenly, rather than reducing cigarette consumption, is associated with increased sustained abstinence. Health providers can enable access and uptake of NRT and/or SSM and should recognise that NRT and/or SSM use may change over time. Consistent messaging, frequent offers of smoking cessation support, and access to a range of smoking cessation supports should be provided to Aboriginal and Torres Strait Islander women to enable them to be smoke-free.]]> Tue 18 Jul 2023 11:15:16 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52542 Tue 17 Oct 2023 10:18:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51608 Tue 12 Sep 2023 13:43:17 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38508 Tue 12 Oct 2021 15:46:00 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38031 Tue 10 Oct 2023 10:11:56 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37282 cat⁻¹ h⁻¹ and a Faradaic efficiency as high as 8.3% at a low overpotential (0.05 V vs the reversible hydrogen electrode), which is far better than that of the bulk Ru counterpart. Moreover, the Ru SAs/g-C₃N₄ displays a high stability during five recycling tests and a 12 h potentiostatic test. Density functional theory calculations reveal that compared to bulk Ru surfaces, Ru SAs/g-C₃N₄ has more facile reaction thermodynamics, and the enhanced NRR performance of Ru SAs/g-C₃N₄ originates from a tuning of the d-electron energies from that of the bulk to a single-atom, causing an up-shift of the d-band center toward the Fermi level.]]> Tue 05 Sep 2023 11:57:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40103 2 is used to study its magnetic properties. In detail, single crystal WSe₂ is codoped with 4 at% Co and various concentrations of Nb by employing the physical ion implantation method. Raman, X-ray diffraction and X-ray photoelectron spectroscopy results reveal the effective substitutional doping of implanted elements (Co and Nb). Magnetic measurements illustrate that both un-doped and 4 at% Co doped WSe₂ show weak ferromagnetism whereas magnetization is strongly enhanced when Co and Nb are codoped into WSe₂. The magnetization is comparable with a ferromagnet, which may be attributed to Co, Nb doping and defects. In addition, a large coercivity of ≈1.2 kOe is observed in the 1 at% Nb–4 at% Co codoped WSe₂ sample, which may be ascribed to the combined effect of doping-induced stress, defect-dictated pinning and anisotropy of Nb-Se bond owing to the charge transfer between Nb and Se ions.]]> Tue 05 Jul 2022 11:09:36 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50548 Tue 01 Aug 2023 10:55:18 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50553 Tue 01 Aug 2023 10:33:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50556 Tue 01 Aug 2023 10:28:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50575 Tue 01 Aug 2023 09:52:01 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45390 Thu 27 Oct 2022 15:02:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50531 Thu 27 Jul 2023 16:26:59 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50520 Thu 27 Jul 2023 15:16:52 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51848 Thu 21 Sep 2023 09:34:47 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41013 Thu 21 Jul 2022 11:54:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37390 Thu 20 Oct 2022 13:19:47 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50338 .8) for most normal cell types and did not require any manual reassignment. The AI digital differential was less reliable for abnormal blood films (r = .50-.87), but could be greatly improved by manual assessment of digital images for most cell types (r > .95) with the exception of immature granulocytes (r = .62). For blast identification, initial AI digital differentials showed 96% sensitivity and 25% specificity, which was improved to 99% and 84%, respectively, after manual digital review.Conclusions: The Techcyte platform allowed remote viewing and manual analysis of digitized slides that was comparable to microscopy. The AI software produced adequate WBC differentials for normal films and had high sensitivity for blast identification in malignant films.]]> Thu 20 Jul 2023 11:18:11 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38461 50=30 nM and 400-fold selective c.f. MCF10A (normal breast tissue). Acetamide moiety modification (13 a-g) to introduce additional hydrophobicity was favoured with MCF-7 breast cancer cell activity enhanced at 1.3 nM. Other analogues were potent against the HT29 colon cancer cell line at 23 nM. Textbook SAR data was observed in the MCF-7 cell line, in an MTT assay, via the ortho (17 a), meta (17 b) and para (13 f). The amino alcohol -OH moiety was pivotal, but no stereochemical preference noted. But, these data did not fit our homology modelling expectations. Aberrant MTT ((3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) screening results and metabolic interference confirmed by sulforhodamine B (SRB) screening. Interfering analogues resulted in 120 and 80-fold CYP1A1 and CYP1A2 amplification, with no upregulation of SULT1A1. This is consistent with activation of the AhR pathway. Piperidine per-deuteration reduced metabolic inactivation. 3-OH / 4-OH piperidine analogues showed differential MTT and SRB activity supporting MTT assay metabolic inactivation. Data supports piperidine 3-OH, but not the 4-OH, as a CYP substrate. This family of β-amino alcohol substituted 3,4-dichlorophenylacetonitriles show broad activity modulated via the AhR pathway. By SRB analysis the most potent analogue was 23 b, (Z)-3-(4-(3-(4-phenylpiperidin-1-yl)-2-hydroxypropoxy)phenyl)-2-(3,4-dichlorophenyl)-acrylonitrile.]]> Thu 18 Nov 2021 10:32:22 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54811 Thu 14 Mar 2024 14:24:56 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50893 Thu 10 Aug 2023 17:07:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50555 Thu 08 Feb 2024 15:27:05 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52818 Mon 30 Oct 2023 08:51:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52819 Mon 30 Oct 2023 08:50:39 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50891 Mon 29 Jan 2024 18:22:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37374 1/2) of Gd₂O₃-Co/NG is 100 mV more positive than that of Co/NG and even close to commercial Pt/C. The density functional theory calculation and spectroscopic analysis demonstrate that, owing to intrinsic charge redistribution at the engineered interface of Gd₂O₃/Co, the coupled Gd₂O₃-Co can break the OOH*-OH* scaling relation and result in a good balance of OOH* and OH* binding on Gd₂O₃-Co surface. For practical application, a rechargeable Zn-air battery employing Gd₂O₃-Co/NG as an air-cathode achieves a large power density and excellent charge-discharge cycle stability.]]> Mon 29 Jan 2024 18:04:04 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45543 4 or Fe-N₄ planar configuration. The developed Ni-N₄/GHSs/Fe-N,₄ Janus material exhibits excellent bifunctional electrocatalytic performance, in which the outer Fe-N₄ clusters dominantly contribute to high activity toward the oxygen reduction reaction (ORR), while the inner Ni-N₄ clusters are responsible for excellent activity toward the oxygen evolution reaction (OER). Density functional theory calculations demonstrate the structures and reactivities of Fe-N₄ and Ni-N₄ for the ORR and OER. The Ni-N₄/GHSs/Fe-N₄ endows a rechargeable Zn–air battery with excellent energy efficiency and cycling stability as an air-cathode, outperforming that of the benchmark Pt/C+RuO₂ air-cathode. The current work paves a new avenue for precise control of single-atom sites on carbon surface for the high-performance and selective electrocatalysts.]]> Mon 29 Jan 2024 18:00:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40107 60 and C₇₀ fullerene (CFEx) and Super-P carbon black were tested and compared as cathodes for non-aqueous aluminium-ion batteries (AIBs). These materials differ in their general structure, porosity and morphology. Fullerenes display a crystalline structure, whereas hemp fibers, Super-P and hair are amorphous in nature. Of all materials, AC obtained from hair recorded the highest specific capacity after 50 cycles at 103 mAh g⁻¹ with a Coulombic efficiency of ∼90 % at a current rate of 50 mA g⁻¹. Both hemp fibers and Super-P achieved their highest specific capacities at 56 mAh g⁻¹ and 84 mAh g⁻¹ respectively. CFEx recorded its highest capacity at 78 mAh g⁻¹ and maintained it for 50 cycles. The cells were charged and discharged to 2.45 V and 0.2 V respectively.]]> Mon 29 Jan 2024 17:43:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54965 Mon 25 Mar 2024 12:04:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46410 Mon 21 Nov 2022 12:20:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37903 Mon 21 Jun 2021 15:18:27 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43430 4) scaffold was produced using counter-gravity infiltration casting method and its in vitro degradation behaviour was evaluated using an electrochemical technique in simulated body fluid (SBF) for potential applications in bone fracture fixation devices. The porous zinc alloy exhibited porosity of ~60% with interconnected pores, and the pore size was 1–2 mm. The in vitro potentiodynamic polarization results showed that the degradation rate of the porous zinc alloy was 0.16 mm/year, which is ~15% higher than that of the non-porous pure zinc metal (0.14 mm/year). Highly biocompatible calcium phosphate (CaP) was electrochemically deposited on the porous zinc alloy and its in vitro degradation behaviour was also studied. The micrographs of the CaP deposited porous zinc alloy revealed uniformly coverage of CaP particles on the outer surface of the alloy and partial deposition on the inside of the pores. The morphology of the deposited CaP particles was predominantly spherical-shaped, but flake-like particles were also evident on the inside of the pores. Interestingly, the degradation rate of the CaP deposited porous zinc alloy (0.5 mm/year) was three times higher than that of the porous zinc alloy. It can be hypothesized that the restricted SBF flow through the partially blocked pores by the CaP particles have locally raised the pH inside the pores and thus increased the degradation.]]> Mon 19 Sep 2022 09:57:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44574 2.0 V) have been reported. Herein, the effects of theoretical mechanisms on voltage window are first introduced, which provide the fundamental guidance to enlarge the voltage window of aqueous SCs. Subsequently, the strategies for constructing the aqueous SCs over 2.0 V are comprehensively summarized and classified into the electrode modification by structural engineering, metal cations doping and constructing advanced composites, and the electrolyte optimization by preparing “Water in Salt” and novel mixed electrolyte. Finally, via the discussion of current progresses and drawbacks of these >2.0 V aqueous SCs, their future development directions are proposed.]]> Mon 17 Oct 2022 11:37:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50305 Mon 17 Jul 2023 11:33:27 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46182 Mon 14 Nov 2022 10:26:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50949 Mon 14 Aug 2023 14:35:52 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55290 Mon 13 May 2024 11:01:54 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55291 Mon 13 May 2024 10:21:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53616 Mon 11 Dec 2023 12:35:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52334 Mon 09 Oct 2023 14:50:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41043 p=.001), use of inhaled corticosteroids (68.2% and RR 2.17, 95% CI 1.19-3.99, p=.001) and short-acting β-agonists in the last 12 months (95.2% and RR 1.49, 95% CI 1.17-1.89, p=.001), as compared to those with RV negative bronchiolitis and no maternal asthma history. More children in this group had an abnormal airway resistance (33.3% and adjusted risk ratio [aRR] 3.11, 95% CI 1.03-9.47, p=.045) and reactance (27.8% and aRR 2.11, 95% CI 1.06-4.26, p=.035) at 5 Hz, as compared to those with RV negative bronchiolitis and no maternal asthma history. Conclusion: Hospitalization for RV positive bronchiolitis in early life combined with a history of maternal asthma identifies a subgroup of children with a high asthma burden while participants with only one of the two risk factors had intermediate risk for asthma.]]> Mon 08 Aug 2022 14:50:18 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36549 Mon 06 Mar 2023 14:23:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38061 Fri 30 Jul 2021 13:30:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50568 Fri 28 Jul 2023 11:34:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50565 Fri 28 Jul 2023 11:27:49 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50557 Fri 28 Jul 2023 10:53:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50549 Fri 28 Jul 2023 10:25:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50539 Fri 28 Jul 2023 09:14:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51231 Fri 25 Aug 2023 15:07:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39338 Fri 25 Aug 2023 10:12:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50356 Fri 21 Jul 2023 11:13:01 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50355 Fri 21 Jul 2023 10:31:13 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50542 Fri 18 Aug 2023 12:00:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50543 Fri 18 Aug 2023 11:51:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50550 Fri 18 Aug 2023 11:44:05 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51742 Fri 15 Sep 2023 18:14:09 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51737 Fri 15 Sep 2023 18:06:50 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51730 Fri 15 Sep 2023 17:59:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38932 -2, a small Tafel slope of 87 mV dec^-1 and prominent durability. Percolation theory was for the first time introduced to interpret the catalytic mechanism of the CD/CF catalysts. The special morphology assembled by the 0D carbons constituted the percolating clusters and promoted electron transport throughout the 1D carbons. The strategy and theory can be adapted to general electrocatalytic applications for achieving and interpreting precise tuning on highly efficient electron transfer in electrocatalysts.]]> Fri 15 Sep 2023 15:54:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51709 Fri 15 Sep 2023 14:09:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37679 Fri 12 Mar 2021 10:57:58 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46111 Fri 11 Nov 2022 14:04:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46087 Fri 11 Nov 2022 09:17:07 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37890 Fri 11 Jun 2021 09:29:09 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47945 Fri 10 Feb 2023 16:20:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50754 Fri 04 Aug 2023 11:34:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49832 Fri 02 Jun 2023 16:03:53 AEST ]]>